Diminishing Availability of Publicly Funded Slots for Antiretroviral Initiation among HIV-Infected ART-Eligible Patients in Uganda

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Geng, Elvin H ^a,e   Bwana, Mwebesa B ^d,e   Kabakyenga, Jerome ^d   Muyindike, Winnie ^d,e   Emenyonu, Nneka I ^c,d   Musinguzi, Nicholas ^d,e   Mugyenyi, Peter ^d   Martin, Jeffrey N ^a,b,e   Bangsberg, David R ^c,d,e  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^e The East Africa International Databases to Evaluate AIDS Consortium ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG INDICATION; FAMILY TREATMENT FUND; FEMALE; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MINISTRY OF HEALTH GLOBAL FUND; PRESIDENTS EMERGENCY PLAN FOR AIDS RELIEF; PUBLIC HEALTH; SURVIVAL; UGANDA; CD4 LYMPHOCYTE COUNT; ECONOMICS; ORGANIZATION AND MANAGEMENT; PROPORTIONAL HAZARDS MODEL; STATISTICS;

ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; ELIGIBILITY DETERMINATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PROPORTIONAL HAZARDS MODELS; UGANDA;

EID: 78649637490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014098     Document Type: Article

References (14)

1. Office of the United States Global AIDS Coordinator. The Power of Partnerships: The President's Emergency Plan for AIDS Relief Fifth Annual Report to Congress 2009, http://www.pepfar.gov/documents/organization/81019.pdf. Accessed July 21, 2010.
2. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a metaanalysis. Jama 296: 679-690.
3. Nguyen VK, Ako CY, Niamba P, Sylla A, Tiendrebeogo I (2007) Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment. AIDS 21 Suppl 5: S31-35.
4. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, et al. (2009) Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 6: e11.
5. Thirumurthy H, Zivin JG, Goldstein M (2008) The Economic Impact of AIDS Treatment. The Journal of Human Resources 43: 511-522.
6. Mwagomba B, Zachariah R, Massaquoi M, Misindi D, Manzi M, et al. Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One 5: e10452.
7. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
8. Rosen S, Fox MP, Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298.
9. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resourcelimited settings. Lancet 368: 505-510.
10. Katabira ET, Kamya MR, Kalyesubula I, Namale A (2009) National Antiretroviral Treatment Guidelines for Adults, Adolescents, and Children. In: Health Mo, ed. 3rd Edition ed. Kampala, Uganda.
11. PEPFAR Uganda ART Halt Memo, http://sciencespeaks.files.wordpress.com/2010/05/memo-oct-halt-treatment-scaleup.pdf. Kampala.
12. No Time to Quite: HIV/AIDS Treatment Gap Widening in Africa, http://www.doctorswithoutborders.org/publications/reports/2010/MSF-No-Time-to-Quit-HIV-AIDS.pdf. Medecins Sans Frontieres.
13. Soni A, Gupta R (2009) Bridging the resource gap: improving value for money in HIV/AIDS treatment. Health Aff (Millwood) 28: 1617-1628.
14. Fox M (2010) Time for efficiency in fighting AIDS: Bill Gates. Washington: Reuters.